World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
43372
World Ranking
9528
National Ranking
4912

David F. Penson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David F. Penson sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 906 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David F. Penson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David F. Penson sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David F. Penson is affiliated with Vanderbilt University Medical Center in the United States. Their research primarily focuses on medicine, with a strong concentration in pulmonary and respiratory medicine, economics and econometrics, surgery, oncology, and general health professions. The main areas of their work include prostate cancer treatment and research, prostate cancer diagnosis and treatment, health systems with economic evaluations and quality of life, economic and financial impacts of cancer, bladder and urothelial cancer treatments, patient-provider communication in healthcare, and cancer-related lipids and metabolism.

Frequent publication venues for David F. Penson include:

  • The Journal of Urology
  • Prostate Cancer and Prostatic Diseases
  • Journal of Clinical Oncology
  • Urologic Oncology Seminars and Original Investigations
  • Urology

David F. Penson has collaborated extensively with several co-authors, notably:

  • Daniel A. Barocas
  • Tatsuki Koyama
  • Li-Ching Huang
  • Zhiguo Zhao
  • Karen E. Hoffman

Their recent publications reflect contributions to significant topics within prostate cancer and oncology. Notable recent papers include:

  • NCCN Guidelines Insights: Prostate Cancer, Version 1.2021 (2021), published in the Journal of the National Comprehensive Cancer Network
  • Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer (2020), published in New England Journal of Medicine
  • Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer (2020), published in JAMA
  • Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry (2020), published in Prostate Cancer and Prostatic Diseases
  • Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease (2022), published in Nature Communications

Best Publications

  • Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

    Philip W. Kantoff;Celestia S. Higano;Neal D. Shore;E. Roy Berger

  • Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia

    Kevin T. McVary;Claus G. Roehrborn;Andrew L. Avins;Michael J. Barry

  • Early detection of prostate cancer: AUA Guideline

    H. Ballentine Carter;Peter C. Albertsen;Michael J. Barry;Ruth Etzioni

  • Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

    Ruth Etzioni;David F. Penson;Julie M. Legler;Dante di Tommaso

  • Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

    James L. Mohler;Emmanuel S. Antonarakis;Andrew J. Armstrong;Anthony V. D'Amico

  • Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer

    Matthew J. Resnick;Tatsuki Koyama;Kang-Hsien Fan;Peter C. Albertsen

  • Epidemiology and cost of ventral hernia repair: making the case for hernia research

    B. K. Poulose;J. Shelton;S. Phillips;D. Moore

  • Overdiagnosis and Overtreatment of Prostate Cancer

    Stacy Loeb;Marc A. Bjurlin;Joseph Nicholson;Teuvo L. Tammela

  • Five-Year Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: The Prostate Cancer Outcomes Study

    Arnold L. Potosky;William W. Davis;Richard M. Hoffman;Janet L. Stanford

  • Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them

    Paul L. Nguyen;Shabbir M.H. Alibhai;Shehzad Basaria;Anthony V. D’Amico

  • Prostate Cancer, Version 1.2016

    James L. Mohler;Andrew J. Armstrong;Robert R. Bahnson;Anthony Victor D'Amico

  • 5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study.

    David F. Penson;Dale McLerran;Ziding Feng;Lin Li

  • Nationwide Trends in Mastectomy for Early-Stage Breast Cancer

    Kristy L. Kummerow;Kristy L. Kummerow;Liping Du;David F. Penson;David F. Penson;Yu Shyr

  • Quantifying the role of PSA screening in the US prostate cancer mortality decline

    Ruth Etzioni;Alex Tsodikov;Alex Tsodikov;Angela Mariotto;Aniko Szabo;Aniko Szabo

  • Prostate Cancer and the Will Rogers Phenomenon

    Peter C. Albertsen;James A. Hanley;George H. Barrows;David F. Penson

  • Prostate cancer, version 1.2021: Featured updates to the nccn guidelines

    Edward Schaeffer;Sandy Srinivas;Emmanuel S. Antonarakis;Andrew J. Armstrong

  • Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years

    Daniel A. Barocas;Jo Ann Alvarez;Matthew J. Resnick;Tatsuki Koyama

  • Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer

    Cora N. Sternberg;Karim Fizazi;Fred Saad;Neal D. Shore

  • Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial

    David F. Penson;Andrew J. Armstrong;Raoul Concepcion;Neeraj Agarwal

  • Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer.

    M.P.H. Steven B. Zeliadt Ph.D.;M.P.H. Steven B. Zeliadt Ph.D.;Scott D. Ramsey M.D.;Scott D. Ramsey M.D.;M.P.H. David F. Penson M.D.;M.P.H. Ingrid J. Hall Ph.D.

Frequent Co-Authors

Ann S. Hamilton
Ann S. Hamilton University of Southern California
Sam S. Chang
Sam S. Chang Vanderbilt University Medical Center
Matthew R. Cooperberg
Matthew R. Cooperberg University of California, San Francisco
Peter C. Albertsen
Peter C. Albertsen University of Connecticut Health Center
Michael S. Cookson
Michael S. Cookson University of Oklahoma
Joseph A. Smith
Joseph A. Smith Vanderbilt University Medical Center
Janet L. Stanford
Janet L. Stanford Fred Hutchinson Cancer Research Center
Sheldon Greenfield
Sheldon Greenfield University of California, Irvine
Scott D. Ramsey
Scott D. Ramsey Fred Hutchinson Cancer Research Center
Mark S. Litwin
Mark S. Litwin University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative or supplementary education in healthcare can broaden your career options beyond traditional medical degrees. Many students are drawn to advanced online programs offering flexibility and accelerated timelines. For example, dnp programs online provide an accessible route for nurses seeking terminal degrees, combining rigorous coursework with remote learning convenience.

Some professionals look for less intensive pathways, such as enrolling in a dnp program without clinical hours, to skip in-person requirements and complete credentials faster. Those beginning their careers in nursing may consider fast track lpn programs online to quickly enter the workforce and gain essential hands-on experience.

Additionally, for those interested in mental health, the shortest post master's pmhnp online programs allow experienced nurses to specialize in psychiatric care efficiently via distance learning. Exploring these related pathways can open doors to specialized or advanced practice roles outside of the traditional medical doctor route.

Best Scientists Citing David F. Penson

Trending Scientists

Recently Published Articles